-
Product Insights
NewLikelihood of Approval Analysis for Ductal Carcinoma
Overview How likely is it that the drugs in Ductal Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ductal Carcinoma Overview Ductal Carcinoma is early stage of breast cancer where...
-
Thematic Analysis
NewRobotics in Construction – Thematic Intelligence
Robotics in Construction Thematic Intelligence Report Overview The construction industry has been generally slow to digitalize and adopt new technologies. As an industry, it relies heavily on manual labor resulting in low productivity growth. Adopting robots can increase safety on construction sites, ensure projects are delivered on time, and help maintain productivity. As costs decrease and the benefits become increasingly evident, construction companies will implement more robots across the ecosystem. The ‘Robotics in Construction’ thematic intelligence report assesses how robotics...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Dapansutrile in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dapansutrile in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dapansutrile in Osteoarthritis Pain Drug Details: Dapansutrile (OLT-1177) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Dapansutrile in Systolic Heart Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dapansutrile in Systolic Heart Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dapansutrile in Systolic Heart Failure Drug Details: Dapansutrile (OLT-1177) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Divozilimab in Neuromyelitis Optica (Devic’s Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Divozilimab in Neuromyelitis Optica (Devic's Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Divozilimab in Neuromyelitis Optica (Devic's Syndrome) Drug Details: Divozilimab (Ivlizi)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy Drug Details: Sacubitril and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab in Type 1 Diabetes (Juvenile Diabetes) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golimumab in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golimumab in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab in Castration-Resistant Prostate Cancer (CRPC) Drug Details: Golimumab...
-
Thematic Analysis
DTx in Medical – Thematic Intelligence
DTX in Medical Thematic Report Overview Digital therapeutics (DTx) are software-based interventions that deliver evidence-based therapeutic interventions to patients. The interventions are driven by high-quality software programs to prevent, manage, or treat a medical condition. The majority of DTx are designed to treat chronic, respiratory, and mental health or neurological conditions. The use of DTx generally requires a prescription, as the interventions must be cleared or certified by regulatory bodies to support their claims. The DTx in medical thematic intelligence...